The regulation of burn-associated infections with herpes simplex virus type 1 or Candida albicans by a non-toxic aconitine-hydrolysate, benzoylmesaconine. Part 1

Antiviral and anti-fungal activities in thermally injured mice

Makiko Kobayashi, Kazuya Mori, Hiroyuki Kobayashi, Richard B Pollard, Fujio Suzuki

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

As compared with normal unburned mice, thermally injured mice have been shown to be 50-100 times more susceptible to HSV type 1 (HSV-1) or Candida albicans infection. Benzoylmesaconine (BEN) improved the resistance of thermally injured mice against infection with HSV-1 or C. albicans to the level observed in normal mice. Mortality rates of normal mice exposed to lethal amounts of these pathogens were not affected by the BEN treatment, while significant survival effects were produced in these mice after treatment with acyclovir (against HSV-1) or amphotericin B (against C. albicans). Benzoylmesaconine did not inhibit the growth of these pathogens in vitro and did not directly reduce the viability of the pathogens. However, burned mice inoculated with CD4+ T cells from BEN-treated mice resisted infections from these pathogens. These results suggested that, through the generation of CD4+ T cells, BEN recovered the impaired resistance of thermally injured mice to infection by HSV-1 or C. albicans.

Original languageEnglish (US)
Pages (from-to)202-208
Number of pages7
JournalImmunology and Cell Biology
Volume76
Issue number3
DOIs
StatePublished - 1998
Externally publishedYes

Fingerprint

Aconitine
Candida
Human Herpesvirus 1
Candida albicans
Burns
Viruses
Antiviral Agents
Pathogens
Infection
T-cells
Acyclovir
Amphotericin B
T-Lymphocytes
benzoylmesaconine

Keywords

  • Benzoylmesaconine
  • Candida albicans
  • HSV
  • Thermal injury

ASJC Scopus subject areas

  • Immunology
  • Clinical Biochemistry
  • Cell Biology

Cite this

@article{ab3f64af442b4ea3bb8024ba147a751f,
title = "The regulation of burn-associated infections with herpes simplex virus type 1 or Candida albicans by a non-toxic aconitine-hydrolysate, benzoylmesaconine. Part 1: Antiviral and anti-fungal activities in thermally injured mice",
abstract = "As compared with normal unburned mice, thermally injured mice have been shown to be 50-100 times more susceptible to HSV type 1 (HSV-1) or Candida albicans infection. Benzoylmesaconine (BEN) improved the resistance of thermally injured mice against infection with HSV-1 or C. albicans to the level observed in normal mice. Mortality rates of normal mice exposed to lethal amounts of these pathogens were not affected by the BEN treatment, while significant survival effects were produced in these mice after treatment with acyclovir (against HSV-1) or amphotericin B (against C. albicans). Benzoylmesaconine did not inhibit the growth of these pathogens in vitro and did not directly reduce the viability of the pathogens. However, burned mice inoculated with CD4+ T cells from BEN-treated mice resisted infections from these pathogens. These results suggested that, through the generation of CD4+ T cells, BEN recovered the impaired resistance of thermally injured mice to infection by HSV-1 or C. albicans.",
keywords = "Benzoylmesaconine, Candida albicans, HSV, Thermal injury",
author = "Makiko Kobayashi and Kazuya Mori and Hiroyuki Kobayashi and Pollard, {Richard B} and Fujio Suzuki",
year = "1998",
doi = "10.1046/j.1440-1711.1998.00735.x",
language = "English (US)",
volume = "76",
pages = "202--208",
journal = "Immunology and Cell Biology",
issn = "0818-9641",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - The regulation of burn-associated infections with herpes simplex virus type 1 or Candida albicans by a non-toxic aconitine-hydrolysate, benzoylmesaconine. Part 1

T2 - Antiviral and anti-fungal activities in thermally injured mice

AU - Kobayashi, Makiko

AU - Mori, Kazuya

AU - Kobayashi, Hiroyuki

AU - Pollard, Richard B

AU - Suzuki, Fujio

PY - 1998

Y1 - 1998

N2 - As compared with normal unburned mice, thermally injured mice have been shown to be 50-100 times more susceptible to HSV type 1 (HSV-1) or Candida albicans infection. Benzoylmesaconine (BEN) improved the resistance of thermally injured mice against infection with HSV-1 or C. albicans to the level observed in normal mice. Mortality rates of normal mice exposed to lethal amounts of these pathogens were not affected by the BEN treatment, while significant survival effects were produced in these mice after treatment with acyclovir (against HSV-1) or amphotericin B (against C. albicans). Benzoylmesaconine did not inhibit the growth of these pathogens in vitro and did not directly reduce the viability of the pathogens. However, burned mice inoculated with CD4+ T cells from BEN-treated mice resisted infections from these pathogens. These results suggested that, through the generation of CD4+ T cells, BEN recovered the impaired resistance of thermally injured mice to infection by HSV-1 or C. albicans.

AB - As compared with normal unburned mice, thermally injured mice have been shown to be 50-100 times more susceptible to HSV type 1 (HSV-1) or Candida albicans infection. Benzoylmesaconine (BEN) improved the resistance of thermally injured mice against infection with HSV-1 or C. albicans to the level observed in normal mice. Mortality rates of normal mice exposed to lethal amounts of these pathogens were not affected by the BEN treatment, while significant survival effects were produced in these mice after treatment with acyclovir (against HSV-1) or amphotericin B (against C. albicans). Benzoylmesaconine did not inhibit the growth of these pathogens in vitro and did not directly reduce the viability of the pathogens. However, burned mice inoculated with CD4+ T cells from BEN-treated mice resisted infections from these pathogens. These results suggested that, through the generation of CD4+ T cells, BEN recovered the impaired resistance of thermally injured mice to infection by HSV-1 or C. albicans.

KW - Benzoylmesaconine

KW - Candida albicans

KW - HSV

KW - Thermal injury

UR - http://www.scopus.com/inward/record.url?scp=0031813968&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031813968&partnerID=8YFLogxK

U2 - 10.1046/j.1440-1711.1998.00735.x

DO - 10.1046/j.1440-1711.1998.00735.x

M3 - Article

VL - 76

SP - 202

EP - 208

JO - Immunology and Cell Biology

JF - Immunology and Cell Biology

SN - 0818-9641

IS - 3

ER -